As part of PDA’s staff development opportunities, five staff members representing PDA’s Education, Marketing, Publications and Scientific and Regulatory Affairs departments, were treated to a tour of the MedImmune pilot facility in Gaithersburg, Md., Aug. 11, to learn how parenterals are started, manufactured and distributed. MedImmune is the global biologics research and development arm of AstraZeneca, focusing on the discovery, development and commercialization of small molecule and biologic prescription medicines. It is one of nine buildings on the Gaithersburg campus.